Previous studies have shown that DTM resistance in L. salmonis is transmitted predominantly by maternal inheritance and associated with mtDNA SNPs13,42. While an earlier study suggested that highly DTM resistant L. salmonis share virtually identical mtDNA sequences13, the present study identified three mtDNA haplotypes associated with resistance, one of which coincides with the previously reported resistance associated mtDNA sequence. L. salmonis strain IoA-10, which possesses one of the novel DTM resistance associated haplotypes, showed a high level of DTM resistance comparable to that of the previously characterised strain IoA02 and, similar to IoA02, passed on DTM resistance to the next generation through maternal inheritance. The phylogenetic analysis of mtDNA haplotypes provided evidence for multiple origins of mtDNAassociated DTM resistance in L. salmonis. Comparison of mtDNA sequences between DTM resistant and susceptible salmon louse strains suggested the association of DTM resistance with SNP T8600C, corresponding to Leu107Ser in COX1.
L. salmonis obtained at aquaculture sites were subjected to bioassays to determine their DTM susceptibility status. Parasites were then genotyped at previously described mtDNA SNP loci13 to identify mitochondrial haplotypes and assess haplotype association with DTM resistance. 93%, 87%, and 100% of lice possessing haplotypes 2, 3, and 4, respectively, were classified as DTM resistant, emphasising the association of mtDNA mutations with the resistance phenotype. The remaining 7-13% may have died due to interacting environmental factors or handling of parasites during sampling, transportation, and set-up of bioassays rather than drug toxicity10,43. As bioassays were performed on lice directly obtained from farmed salmon, environmental conditions prior sampling could not be controlled. Lice may have also been exposed to stressful conditions during sampling and due to abrupt changes of environmental conditions during transportation. The DTM resistance phenotype was less distinct for lice containing haplotype 1. While most lice with this haplotype were classified as DTM susceptible, 43% were rated resistant. The large number of resistant haplotype 1 individuals suggests the contribution of genetic factors other than mitochondrial mutations to the DTM resistance phenotype, which is in line with findings by Carmona-Antoñanzas et al.13 who attributed the presence of about 20% resistant F2 parasites in a family descending from a DTM susceptible dam and a resistant sire to nuclear genetic determinants of resistance.
To address confounding factors in bioassays on lice directly collected from farmed salmon, this study included analogous experiments with copepodid larvae derived from eggs of one female. When investigating effects of mtDNA mutations on drug resistance, advantages of F1 bioassays with copepodid larvae are that sibling clutches share the same mitochondrial haplotype 44 and were hatched and reared under standardized laboratory conditions less likely to bias the outcome of the experiment. While insufficient gravid females of appropriate genotype precluded analysis of haplotype 4 in copepodid bioassays, testing of larvae of the remaining haplotypes resolved significant differences in drug resistance between L. salmonis of haplotypes 2 and 3 as compared to parasites of haplotype 1, confirming results from conventional bioassays and underpinning the association of mtDNA mutations with DTM resistance. Moreover, the study showed that DTM resistance is already present in the larval stage, which would be expected for resistance conferred by mtDNA mutations13.
Genotyping of field isolates collected in 2018 and 2019 revealed three DTM resistance-associated mtDNA haplotypes, with haplotypes 2, 3, and 4 being found in 75%, 14% and 8% of all resistant lice, respectively. Analysis of archived samples further provided evidence for haplotypes 4 being present in parasites removed from wild salmon in 2010, while haplotypes 3 and 4 were found in the DTM resistant strain NA01-O, which was established in 2013. These findings contrast with results from Carmona-Antoñanzas et al.13, who reported mtDNA sequences consistent with haplotype 2 for all DTM resistant isolates analysed in their study. Moreover, no resistance-associated haplotypes were evident from parasites collected from wild salmon in 2010. The failure to detect the less frequent haplotypes 3 and 4 in the earlier study13 could be attributed to the limited number of sequenced individuals.
Phylogenetic analyses of mtDNA haplotypes showed that the three DTM resistance-associated haplotypes fall into two clusters, with haplotype 3 being phylogenetically distant to haplotypes 2 and 4, which shared 17 out of 18 tested SNP loci. This mtDNA sequence variability in DTM resistant isolates indicate that mtDNA-associated DTM resistance in L. salmonis originated from at least two independent origins. Thus, resistanceassociated mitochondrial mutation(s) may have been selected for, more or less in parallel, as a consequence of the extensive use of pyrethroids.
Resistance-associated haplotypes 2 and 3 differed maximally in sequence, with only one out of 18 tested SNP loci being shared. To investigate the relationship of haplotypes 2 and 3 to DTM resistance, the present study performed comparative experiments with strain IoA-02 containing haplotype 2 and strain IoA-10 containing haplotype 3. Despite haplotypes 2 and 3 being very different in sequence, their resistance phenotype is very similar. Both IoA-10 (haplotype 3) and IoA-02 (haplotype 2) lice were highly DTM resistant (EC50 values >24.0 µg/L; P = 0.845) and reciprocal crosses of strains IoA-10 (present study) and IoA-0213 with the drugsusceptible IoA00 lice revealed that both strains transmit their resistance to the next generation through maternal inheritance. Moreover, DTM exposure caused behavioural toxicity and wholebody ATP depletion in DTM susceptible IoA-00 parasites, but not resistant IoA-10 and IoA-02 lice. These findings are in line with an earlier experiment, which compared the effect of DTM exposure on behavioural toxicity and ATP levels between IoA-00 and IoA-02 lice13. The maternal inheritance of DTM resistance in families derived from a resistant dam provide evidence that the resistance phenotype is conferred by the maternally transmitted mitochondrial genome, which has been discussed in detail elsewhere13. Depletion of ATP levels in DTM susceptible lice may be related to the toxic effect of DTM on the mitochondria, and mtDNA mutations in haplotypes 2 and 3 may have a protective effect.
As the inheritance of mtDNA is linear and lacks recombination through meiosis, relevant SNPs for DTM resistance are transmitted together with irrelevant hitchhiking SNPs44. Thus, SNPs that are truly linked to DTM resistance are expected to be present in all resistanceassociated haplotypes but lacking in all susceptibilityassociated haplotypes. The nonsynonymous mtDNA SNP T8600C, corresponding to Leu107Ser in COX1, was the only mutation shared by the resistance-associated haplotypes 2, 3, and 4 and lacking in all susceptibility-associated haplotypes. When comparing mtDNA sequences of DTM resistant and susceptible lice, T8600C was also the only non-synonymous mutation differentiating between resistant and susceptible individuals. Sequencing analyses further revealed eight additional SNPs in non-coding regions (NCR) of the mtDNA that were common to all resistant lice and lacking in all susceptible lice. NCR sequences are the most variable mtDNA sequences, which may explain the high number of SNPs found within this region in the present study45. Seven of these SNPs were found in the mitochondrial control region, also known as displacement loop (D-loop). Its function is not yet fully understood but seems to be critical in regulating replication and transcription of mtDNA46. However, D-loop mutations are not known to confer drug resistance. Another SNP, A10178G, was found within a mitochondrial ribosomal RNA (rRNA) gene and has also been described by Bakke et al.18. Mitochondrial rRNAs are assembled with ribosomal proteins encoded by nuclear genes to form mitochondrial ribosomes, which are responsible for translating mitochondrial proteins47. Thus, mutation within the mitochondrial rRNA may lead to ribosome dysfunction and may result in respiratory chain defects 48. However, to our knowledge, there are no reports of mitochondrial rRNA mutations associated with drug resistance.
Findings of the present study raise questions about the mechanism of DTM resistance and by inference the mechanism of DTM toxicity in L. salmonis. While it is generally accepted that pyrethroids target Nav in terrestrial arthopods14, several studies with terrestrial arthropods and mammals provide evidence for pyrethroid effects on mitochondrial functions. Due to their lipophilic nature, pyrethroids can pass and interact with biological membranes, making mitochondrial membranes and membrane proteins candidate targets for toxic action49. For example, pyrethroids have been shown to affect mitochondrial membrane structures and dynamics, which can impair oxidative phosphorylation50,51. Mitochondrial oxidative phosphorylation can also be impaired by intracellular Ca2+ accumulation52,53, which can result from interactions of pyrethroids with Nav and consequent Ca2+ influx54 and direct effects of pyrethroids on voltage-gated Ca2+ channels55.
Pyrethroid induced disruption of mitochondrial membrane integrity and inhibition of respiratory complexes, as well as intracellular Ca2+ accumulation can cause the generation of reactive oxygen species (ROS) in mitochondria56–58. ROS can trigger a cascade of reactions that induces lipid peroxidation and damage of macromolecules59–61. Pyrethroids have been shown to induce intrinsic mitochondrial apoptosis62,63, which involves mitochondrial outer membrane permeabilization, release of cytochrome C into the cytosol, activation of caspases, and ultimately DNA fragmentation64. In particular, this pathway can be triggered by pyrethroid induced oxidative stress and Ca2+ accumulation, as well as low levels of ATP that lead to disruption of the mitochondrial transmembrane potential65–68. Interestingly, DTM exposure increased apoptosis in mitochondria-rich skeletal muscle, subcuticular tissue, and central ganglion cells in salmon lice of a drug susceptible strain, but not or to a lesser degree in a DTM resistant strain18.
Taken together, in salmon lice, DTM may induce toxicity through disruption of mitochondrial membranes, direct inhibition of mitochondrial respiratory complex(es), intracellular Ca2+ accumulation, or by causing oxidative stress. An obvious explanation for DTM toxicity in salmon lice would be that DTM or its metabolites are binding to a mitochondrial respiratory complex and lead to disruption of the mitochondrial ATP production, which has been observed in the present study. In addition, inhibition of respiratory complexes can lead to the formation of ROS56. Both, low levels of ATP and oxidative stress can in turn induce intrinsic mitochondrial apoptosis65,66,68, which has been described by Bakke et al.18. Resistance may be conferred by mitochondrial SNP(s) that changes the amino-acid sequences of the complex and impair binding of DTM. For reasons explained above, T8600C leading to Leu107Ser in COX1 is the most probable mutation for conferring DTM resistance in salmon lice. Alternatively, DTM might impair the mitochondrial ATP production in susceptible lice by causing disruptions of the mitochondrial membrane or by secondary effects arising from DTM toxicity. In these scenarios, mtDNA mutation(s) may have functional effects on the efficiency of electron transfer or proton translocation, counteracting ATP deficits.